Tilray France
About Tilray France
Tilray France is the French operations division of Canadian cannabis giant Tilray, participating in France's medical cannabis pilot program launched in 2021.
Key Facts
- 1Selected as a supplier for France's medical cannabis experimentation program
- 2Part of Tilray Brands, one of the world's largest cannabis companies
Latest News
Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis
TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.
Tilray Enters European Cannabis Policy Talks as Regulatory Shift Looms
TLRY participates in EU regulatory discussions as European cannabis markets prepare for potential liberalization across multiple jurisdictions.
Canadian Cannabis Giants Show Mixed Signals Amid Market Consolidation
TLRY, CGC, and VFF navigate regulatory headwinds and operational challenges as the sector searches for sustainable growth paths in 2024.
Frequently Asked Questions
Is medical cannabis legal in France?
France launched a medical cannabis pilot program in 2021, allowing select patients to access cannabis-based treatments through authorized suppliers like Tilray.
How can French patients access Tilray products?
Patients must be enrolled in the French medical cannabis experimentation program through their physician and an authorized hospital or clinic.
More Cannabis Companies in Paris
Cannabis Laws
Products
- Medical cannabis oils
- Dried medical cannabis
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Paris, France
- Founded
- 2021
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY